BC with HER2 IHC score 2+ that lacks evidence of HER2 gene amplification is currently classified as HER2‐negative similar to cases showing IHC score of 0 or 1+5, 6 and do not benefit from anti‐HER2 therapy. The gene discussed is ERBB2; the disease is breast cancer.